Summary

The global PROTAC Therapy Drugs market size is predicted to grow from US$ million in 2025 to US$ 406 million in 2032; it is expected to grow at a CAGR of 26.3% from 2026 to 2032.
PROTAC therapy drugs are a class of small-molecule targeted protein degradation therapies based on Proteolysis-Targeting Chimera (PROTAC) technology. Instead of inhibiting a disease-causing protein’s activity, PROTAC drugs work by inducing the selective degradation of the target protein inside the cell. They achieve this by simultaneously binding the target protein and an E3 ubiquitin ligase, bringing the two into proximity so the target is tagged with ubiquitin and subsequently destroyed by the cell’s proteasome.
PROTAC therapy drugs are an emerging class of small-molecule medicines designed to treat disease by selectively removing, rather than merely inhibiting, specific proteins through the cell’s own ubiquitin?proteasome degradation system. This “event-driven” mechanism addresses several persistent pain points in drug development: it can overcome situations where conventional inhibitors lose effectiveness due to resistance mutations, it can achieve deeper and more sustained pathway control by eliminating the target protein altogether, and it opens new possibilities for proteins that are difficult to modulate with classic active-site binding strategies. Industry momentum is being fueled by rapid advances in target biology and structural design, growing confidence in the translational value of targeted protein degradation, and strong demand in areas such as oncology and immune-mediated diseases where durable responses and differentiation matter most. Looking ahead, market potential is supported by an expanding pipeline of degrader programs, improving chemistry and drug-like properties that enable more practical dosing and broader tissue reach, and the likelihood that successful PROTACs will complement?rather than simply replace?existing targeted therapies, creating a meaningful new layer of precision medicine built around controlling protein levels instead of just protein activity.
PROTAC Therapy Drugs' upstream raw materials mainly include target protein (POI) ligands, E3 ligase ligands, excipients, etc. Typical suppliers include Bio-Techne, Merck, Sigma-Aldrich, Enamine, etc. Downstream applications are mainly in the treatment of cancer, immune diseases, etc.
United States market for PROTAC Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for PROTAC Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for PROTAC Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key PROTAC Therapy Drugs players cover Arvinas, Kymera, Nurix, C4 Therapeutics, BMS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “PROTAC Therapy Drugs Industry Forecast” looks at past sales and reviews total world PROTAC Therapy Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected PROTAC Therapy Drugs sales for 2026 through 2032. With PROTAC Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PROTAC Therapy Drugs industry.
This Insight Report provides a comprehensive analysis of the global PROTAC Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PROTAC Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PROTAC Therapy Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PROTAC Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PROTAC Therapy Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of PROTAC Therapy Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Degradation of Transcription Factors Type
Degradation of Scaffold Proteins Type
Others
Segmentation by Administration Route:
Oral Drugs
Injectable Drugs
Others
Segmentation by E3 Ligase:
CRBN-recruiting PROTACs
VHL-recruiting PROTACs
IAP-recruiting PROTACs
Others
Segmentation by Application:
Cancer
Immune Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Arvinas
Kymera
Nurix
C4 Therapeutics
BMS
Cullgen
Kintor Pharma
Prelude Therapeutics
AbbVie
Accutar
AnHorn Medicines
Astellas
Auron Therapeutics
Axter Therapeutics
Biotheryx
Dialectic Therapeutics
Hinova
Hinova Pharmaceuticals
Haisco
Leadingtac
Mitsubishi Tanabe Pharma America
NiKang Therapeutics
Ubix Therapeutics
Foghorn Therapeutics
Beigene, Ltd.
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Simcere Pharma
Chia Tai Tianqing Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global PROTAC Therapy Drugs market?
What factors are driving PROTAC Therapy Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PROTAC Therapy Drugs market opportunities vary by end market size?
How does PROTAC Therapy Drugs break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PROTAC Therapy Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PROTAC Therapy Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PROTAC Therapy Drugs by Country/Region, 2021, 2025 & 2032
2.2 PROTAC Therapy Drugs Segment by Type
2.2.1 Degradation of Transcription Factors Type
2.2.2 Degradation of Scaffold Proteins Type
2.2.3 Others
2.2.4 PROTAC Therapy Drugs Sales by Type
2.2.4.1 Global PROTAC Therapy Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global PROTAC Therapy Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global PROTAC Therapy Drugs Sale Price by Type (2021-2026)
2.3 PROTAC Therapy Drugs Segment by Administration Route
2.3.1 Oral Drugs
2.3.2 Injectable Drugs
2.3.3 Others
2.3.4 PROTAC Therapy Drugs Sales by Administration Route
2.3.4.1 Global PROTAC Therapy Drugs Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global PROTAC Therapy Drugs Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global PROTAC Therapy Drugs Sale Price by Administration Route (2021-2026)
2.4 PROTAC Therapy Drugs Segment by E3 Ligase
2.4.1 CRBN-recruiting PROTACs
2.4.2 VHL-recruiting PROTACs
2.4.3 IAP-recruiting PROTACs
2.4.4 Others
2.4.5 PROTAC Therapy Drugs Sales by E3 Ligase
2.4.5.1 Global PROTAC Therapy Drugs Sales Market Share by E3 Ligase (2021-2026)
2.4.5.2 Global PROTAC Therapy Drugs Revenue and Market Share by E3 Ligase (2021-2026)
2.4.5.3 Global PROTAC Therapy Drugs Sale Price by E3 Ligase (2021-2026)
2.5 PROTAC Therapy Drugs Segment by Application
2.5.1 Cancer
2.5.2 Immune Diseases
2.5.3 Others
2.5.4 PROTAC Therapy Drugs Sales by Application
2.5.4.1 Global PROTAC Therapy Drugs Sale Market Share by Application (2021-2026)
2.5.4.2 Global PROTAC Therapy Drugs Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global PROTAC Therapy Drugs Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global PROTAC Therapy Drugs Breakdown Data by Company
3.1.1 Global PROTAC Therapy Drugs Annual Sales by Company (2021-2026)
3.1.2 Global PROTAC Therapy Drugs Sales Market Share by Company (2021-2026)
3.2 Global PROTAC Therapy Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global PROTAC Therapy Drugs Revenue by Company (2021-2026)
3.2.2 Global PROTAC Therapy Drugs Revenue Market Share by Company (2021-2026)
3.3 Global PROTAC Therapy Drugs Sale Price by Company
3.4 Key Manufacturers PROTAC Therapy Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PROTAC Therapy Drugs Product Location Distribution
3.4.2 Players PROTAC Therapy Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for PROTAC Therapy Drugs by Geographic Region
4.1 World Historic PROTAC Therapy Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global PROTAC Therapy Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PROTAC Therapy Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PROTAC Therapy Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global PROTAC Therapy Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global PROTAC Therapy Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas PROTAC Therapy Drugs Sales Growth
4.4 APAC PROTAC Therapy Drugs Sales Growth
4.5 Europe PROTAC Therapy Drugs Sales Growth
4.6 Middle East & Africa PROTAC Therapy Drugs Sales Growth
5 Americas
5.1 Americas PROTAC Therapy Drugs Sales by Country
5.1.1 Americas PROTAC Therapy Drugs Sales by Country (2021-2026)
5.1.2 Americas PROTAC Therapy Drugs Revenue by Country (2021-2026)
5.2 Americas PROTAC Therapy Drugs Sales by Type (2021-2026)
5.3 Americas PROTAC Therapy Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PROTAC Therapy Drugs Sales by Region
6.1.1 APAC PROTAC Therapy Drugs Sales by Region (2021-2026)
6.1.2 APAC PROTAC Therapy Drugs Revenue by Region (2021-2026)
6.2 APAC PROTAC Therapy Drugs Sales by Type (2021-2026)
6.3 APAC PROTAC Therapy Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe PROTAC Therapy Drugs by Country
7.1.1 Europe PROTAC Therapy Drugs Sales by Country (2021-2026)
7.1.2 Europe PROTAC Therapy Drugs Revenue by Country (2021-2026)
7.2 Europe PROTAC Therapy Drugs Sales by Type (2021-2026)
7.3 Europe PROTAC Therapy Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa PROTAC Therapy Drugs by Country
8.1.1 Middle East & Africa PROTAC Therapy Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa PROTAC Therapy Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa PROTAC Therapy Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa PROTAC Therapy Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PROTAC Therapy Drugs
10.3 Manufacturing Process Analysis of PROTAC Therapy Drugs
10.4 Industry Chain Structure of PROTAC Therapy Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PROTAC Therapy Drugs Distributors
11.3 PROTAC Therapy Drugs Customer
12 World Forecast Review for PROTAC Therapy Drugs by Geographic Region
12.1 Global PROTAC Therapy Drugs Market Size Forecast by Region
12.1.1 Global PROTAC Therapy Drugs Forecast by Region (2027-2032)
12.1.2 Global PROTAC Therapy Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PROTAC Therapy Drugs Forecast by Type (2027-2032)
12.7 Global PROTAC Therapy Drugs Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 Arvinas
13.1.1 Arvinas Company Information
13.1.2 Arvinas PROTAC Therapy Drugs Product Portfolios and Specifications
13.1.3 Arvinas PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Arvinas Main Business Overview
13.1.5 Arvinas Latest Developments
13.2 Kymera
13.2.1 Kymera Company Information
13.2.2 Kymera PROTAC Therapy Drugs Product Portfolios and Specifications
13.2.3 Kymera PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kymera Main Business Overview
13.2.5 Kymera Latest Developments
13.3 Nurix
13.3.1 Nurix Company Information
13.3.2 Nurix PROTAC Therapy Drugs Product Portfolios and Specifications
13.3.3 Nurix PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nurix Main Business Overview
13.3.5 Nurix Latest Developments
13.4 C4 Therapeutics
13.4.1 C4 Therapeutics Company Information
13.4.2 C4 Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.4.3 C4 Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 C4 Therapeutics Main Business Overview
13.4.5 C4 Therapeutics Latest Developments
13.5 BMS
13.5.1 BMS Company Information
13.5.2 BMS PROTAC Therapy Drugs Product Portfolios and Specifications
13.5.3 BMS PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BMS Main Business Overview
13.5.5 BMS Latest Developments
13.6 Cullgen
13.6.1 Cullgen Company Information
13.6.2 Cullgen PROTAC Therapy Drugs Product Portfolios and Specifications
13.6.3 Cullgen PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cullgen Main Business Overview
13.6.5 Cullgen Latest Developments
13.7 Kintor Pharma
13.7.1 Kintor Pharma Company Information
13.7.2 Kintor Pharma PROTAC Therapy Drugs Product Portfolios and Specifications
13.7.3 Kintor Pharma PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kintor Pharma Main Business Overview
13.7.5 Kintor Pharma Latest Developments
13.8 Prelude Therapeutics
13.8.1 Prelude Therapeutics Company Information
13.8.2 Prelude Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.8.3 Prelude Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Prelude Therapeutics Main Business Overview
13.8.5 Prelude Therapeutics Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie PROTAC Therapy Drugs Product Portfolios and Specifications
13.9.3 AbbVie PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Accutar
13.10.1 Accutar Company Information
13.10.2 Accutar PROTAC Therapy Drugs Product Portfolios and Specifications
13.10.3 Accutar PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Accutar Main Business Overview
13.10.5 Accutar Latest Developments
13.11 AnHorn Medicines
13.11.1 AnHorn Medicines Company Information
13.11.2 AnHorn Medicines PROTAC Therapy Drugs Product Portfolios and Specifications
13.11.3 AnHorn Medicines PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 AnHorn Medicines Main Business Overview
13.11.5 AnHorn Medicines Latest Developments
13.12 Astellas
13.12.1 Astellas Company Information
13.12.2 Astellas PROTAC Therapy Drugs Product Portfolios and Specifications
13.12.3 Astellas PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Astellas Main Business Overview
13.12.5 Astellas Latest Developments
13.13 Auron Therapeutics
13.13.1 Auron Therapeutics Company Information
13.13.2 Auron Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.13.3 Auron Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Auron Therapeutics Main Business Overview
13.13.5 Auron Therapeutics Latest Developments
13.14 Axter Therapeutics
13.14.1 Axter Therapeutics Company Information
13.14.2 Axter Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.14.3 Axter Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Axter Therapeutics Main Business Overview
13.14.5 Axter Therapeutics Latest Developments
13.15 Biotheryx
13.15.1 Biotheryx Company Information
13.15.2 Biotheryx PROTAC Therapy Drugs Product Portfolios and Specifications
13.15.3 Biotheryx PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Biotheryx Main Business Overview
13.15.5 Biotheryx Latest Developments
13.16 Dialectic Therapeutics
13.16.1 Dialectic Therapeutics Company Information
13.16.2 Dialectic Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.16.3 Dialectic Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Dialectic Therapeutics Main Business Overview
13.16.5 Dialectic Therapeutics Latest Developments
13.17 Hinova
13.17.1 Hinova Company Information
13.17.2 Hinova PROTAC Therapy Drugs Product Portfolios and Specifications
13.17.3 Hinova PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Hinova Main Business Overview
13.17.5 Hinova Latest Developments
13.18 Hinova Pharmaceuticals
13.18.1 Hinova Pharmaceuticals Company Information
13.18.2 Hinova Pharmaceuticals PROTAC Therapy Drugs Product Portfolios and Specifications
13.18.3 Hinova Pharmaceuticals PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Hinova Pharmaceuticals Main Business Overview
13.18.5 Hinova Pharmaceuticals Latest Developments
13.19 Haisco
13.19.1 Haisco Company Information
13.19.2 Haisco PROTAC Therapy Drugs Product Portfolios and Specifications
13.19.3 Haisco PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Haisco Main Business Overview
13.19.5 Haisco Latest Developments
13.20 Leadingtac
13.20.1 Leadingtac Company Information
13.20.2 Leadingtac PROTAC Therapy Drugs Product Portfolios and Specifications
13.20.3 Leadingtac PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Leadingtac Main Business Overview
13.20.5 Leadingtac Latest Developments
13.21 Mitsubishi Tanabe Pharma America
13.21.1 Mitsubishi Tanabe Pharma America Company Information
13.21.2 Mitsubishi Tanabe Pharma America PROTAC Therapy Drugs Product Portfolios and Specifications
13.21.3 Mitsubishi Tanabe Pharma America PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Mitsubishi Tanabe Pharma America Main Business Overview
13.21.5 Mitsubishi Tanabe Pharma America Latest Developments
13.22 NiKang Therapeutics
13.22.1 NiKang Therapeutics Company Information
13.22.2 NiKang Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.22.3 NiKang Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 NiKang Therapeutics Main Business Overview
13.22.5 NiKang Therapeutics Latest Developments
13.23 Ubix Therapeutics
13.23.1 Ubix Therapeutics Company Information
13.23.2 Ubix Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.23.3 Ubix Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Ubix Therapeutics Main Business Overview
13.23.5 Ubix Therapeutics Latest Developments
13.24 Foghorn Therapeutics
13.24.1 Foghorn Therapeutics Company Information
13.24.2 Foghorn Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
13.24.3 Foghorn Therapeutics PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Foghorn Therapeutics Main Business Overview
13.24.5 Foghorn Therapeutics Latest Developments
13.25 Beigene, Ltd.
13.25.1 Beigene, Ltd. Company Information
13.25.2 Beigene, Ltd. PROTAC Therapy Drugs Product Portfolios and Specifications
13.25.3 Beigene, Ltd. PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Beigene, Ltd. Main Business Overview
13.25.5 Beigene, Ltd. Latest Developments
13.26 Jiangsu Hengrui Medicine
13.26.1 Jiangsu Hengrui Medicine Company Information
13.26.2 Jiangsu Hengrui Medicine PROTAC Therapy Drugs Product Portfolios and Specifications
13.26.3 Jiangsu Hengrui Medicine PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Jiangsu Hengrui Medicine Main Business Overview
13.26.5 Jiangsu Hengrui Medicine Latest Developments
13.27 Qilu Pharmaceutical
13.27.1 Qilu Pharmaceutical Company Information
13.27.2 Qilu Pharmaceutical PROTAC Therapy Drugs Product Portfolios and Specifications
13.27.3 Qilu Pharmaceutical PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Qilu Pharmaceutical Main Business Overview
13.27.5 Qilu Pharmaceutical Latest Developments
13.28 Simcere Pharma
13.28.1 Simcere Pharma Company Information
13.28.2 Simcere Pharma PROTAC Therapy Drugs Product Portfolios and Specifications
13.28.3 Simcere Pharma PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Simcere Pharma Main Business Overview
13.28.5 Simcere Pharma Latest Developments
13.29 Chia Tai Tianqing Pharmaceutical
13.29.1 Chia Tai Tianqing Pharmaceutical Company Information
13.29.2 Chia Tai Tianqing Pharmaceutical PROTAC Therapy Drugs Product Portfolios and Specifications
13.29.3 Chia Tai Tianqing Pharmaceutical PROTAC Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
13.29.5 Chia Tai Tianqing Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. PROTAC Therapy Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PROTAC Therapy Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Degradation of Transcription Factors Type
Table 4. Major Players of Degradation of Scaffold Proteins Type
Table 5. Major Players of Others
Table 6. Global PROTAC Therapy Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global PROTAC Therapy Drugs Sales Market Share by Type (2021-2026)
Table 8. Global PROTAC Therapy Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global PROTAC Therapy Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global PROTAC Therapy Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Oral Drugs
Table 12. Major Players of Injectable Drugs
Table 13. Major Players of Others
Table 14. Global PROTAC Therapy Drugs Sales by Administration Route (2021-2026) & (K Units)
Table 15. Global PROTAC Therapy Drugs Sales Market Share by Administration Route (2021-2026)
Table 16. Global PROTAC Therapy Drugs Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global PROTAC Therapy Drugs Revenue Market Share by Administration Route (2021-2026)
Table 18. Global PROTAC Therapy Drugs Sale Price by Administration Route (2021-2026) & (US$/Unit)
Table 19. Major Players of CRBN-recruiting PROTACs
Table 20. Major Players of VHL-recruiting PROTACs
Table 21. Major Players of IAP-recruiting PROTACs
Table 22. Major Players of Others
Table 23. Global PROTAC Therapy Drugs Sales by E3 Ligase (2021-2026) & (K Units)
Table 24. Global PROTAC Therapy Drugs Sales Market Share by E3 Ligase (2021-2026)
Table 25. Global PROTAC Therapy Drugs Revenue by E3 Ligase (2021-2026) & ($ million)
Table 26. Global PROTAC Therapy Drugs Revenue Market Share by E3 Ligase (2021-2026)
Table 27. Global PROTAC Therapy Drugs Sale Price by E3 Ligase (2021-2026) & (US$/Unit)
Table 28. Global PROTAC Therapy Drugs Sale by Application (2021-2026) & (K Units)
Table 29. Global PROTAC Therapy Drugs Sale Market Share by Application (2021-2026)
Table 30. Global PROTAC Therapy Drugs Revenue by Application (2021-2026) & ($ million)
Table 31. Global PROTAC Therapy Drugs Revenue Market Share by Application (2021-2026)
Table 32. Global PROTAC Therapy Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global PROTAC Therapy Drugs Sales by Company (2021-2026) & (K Units)
Table 34. Global PROTAC Therapy Drugs Sales Market Share by Company (2021-2026)
Table 35. Global PROTAC Therapy Drugs Revenue by Company (2021-2026) & ($ millions)
Table 36. Global PROTAC Therapy Drugs Revenue Market Share by Company (2021-2026)
Table 37. Global PROTAC Therapy Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers PROTAC Therapy Drugs Producing Area Distribution and Sales Area
Table 39. Players PROTAC Therapy Drugs Products Offered
Table 40. PROTAC Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global PROTAC Therapy Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global PROTAC Therapy Drugs Sales Market Share Geographic Region (2021-2026)
Table 45. Global PROTAC Therapy Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global PROTAC Therapy Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global PROTAC Therapy Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global PROTAC Therapy Drugs Sales Market Share by Country/Region (2021-2026)
Table 49. Global PROTAC Therapy Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global PROTAC Therapy Drugs Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas PROTAC Therapy Drugs Sales by Country (2021-2026) & (K Units)
Table 52. Americas PROTAC Therapy Drugs Sales Market Share by Country (2021-2026)
Table 53. Americas PROTAC Therapy Drugs Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas PROTAC Therapy Drugs Sales by Type (2021-2026) & (K Units)
Table 55. Americas PROTAC Therapy Drugs Sales by Application (2021-2026) & (K Units)
Table 56. APAC PROTAC Therapy Drugs Sales by Region (2021-2026) & (K Units)
Table 57. APAC PROTAC Therapy Drugs Sales Market Share by Region (2021-2026)
Table 58. APAC PROTAC Therapy Drugs Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC PROTAC Therapy Drugs Sales by Type (2021-2026) & (K Units)
Table 60. APAC PROTAC Therapy Drugs Sales by Application (2021-2026) & (K Units)
Table 61. Europe PROTAC Therapy Drugs Sales by Country (2021-2026) & (K Units)
Table 62. Europe PROTAC Therapy Drugs Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe PROTAC Therapy Drugs Sales by Type (2021-2026) & (K Units)
Table 64. Europe PROTAC Therapy Drugs Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa PROTAC Therapy Drugs Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa PROTAC Therapy Drugs Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa PROTAC Therapy Drugs Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa PROTAC Therapy Drugs Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of PROTAC Therapy Drugs
Table 70. Key Market Challenges & Risks of PROTAC Therapy Drugs
Table 71. Key Industry Trends of PROTAC Therapy Drugs
Table 72. PROTAC Therapy Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. PROTAC Therapy Drugs Distributors List
Table 75. PROTAC Therapy Drugs Customer List
Table 76. Global PROTAC Therapy Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global PROTAC Therapy Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas PROTAC Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas PROTAC Therapy Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC PROTAC Therapy Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC PROTAC Therapy Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe PROTAC Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe PROTAC Therapy Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa PROTAC Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa PROTAC Therapy Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global PROTAC Therapy Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global PROTAC Therapy Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global PROTAC Therapy Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global PROTAC Therapy Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Arvinas Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Arvinas PROTAC Therapy Drugs Product Portfolios and Specifications
Table 92. Arvinas PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Arvinas Main Business
Table 94. Arvinas Latest Developments
Table 95. Kymera Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Kymera PROTAC Therapy Drugs Product Portfolios and Specifications
Table 97. Kymera PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Kymera Main Business
Table 99. Kymera Latest Developments
Table 100. Nurix Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Nurix PROTAC Therapy Drugs Product Portfolios and Specifications
Table 102. Nurix PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Nurix Main Business
Table 104. Nurix Latest Developments
Table 105. C4 Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. C4 Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 107. C4 Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. C4 Therapeutics Main Business
Table 109. C4 Therapeutics Latest Developments
Table 110. BMS Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. BMS PROTAC Therapy Drugs Product Portfolios and Specifications
Table 112. BMS PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. BMS Main Business
Table 114. BMS Latest Developments
Table 115. Cullgen Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Cullgen PROTAC Therapy Drugs Product Portfolios and Specifications
Table 117. Cullgen PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Cullgen Main Business
Table 119. Cullgen Latest Developments
Table 120. Kintor Pharma Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Kintor Pharma PROTAC Therapy Drugs Product Portfolios and Specifications
Table 122. Kintor Pharma PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Kintor Pharma Main Business
Table 124. Kintor Pharma Latest Developments
Table 125. Prelude Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Prelude Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 127. Prelude Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Prelude Therapeutics Main Business
Table 129. Prelude Therapeutics Latest Developments
Table 130. AbbVie Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. AbbVie PROTAC Therapy Drugs Product Portfolios and Specifications
Table 132. AbbVie PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. AbbVie Main Business
Table 134. AbbVie Latest Developments
Table 135. Accutar Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Accutar PROTAC Therapy Drugs Product Portfolios and Specifications
Table 137. Accutar PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Accutar Main Business
Table 139. Accutar Latest Developments
Table 140. AnHorn Medicines Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. AnHorn Medicines PROTAC Therapy Drugs Product Portfolios and Specifications
Table 142. AnHorn Medicines PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. AnHorn Medicines Main Business
Table 144. AnHorn Medicines Latest Developments
Table 145. Astellas Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Astellas PROTAC Therapy Drugs Product Portfolios and Specifications
Table 147. Astellas PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Astellas Main Business
Table 149. Astellas Latest Developments
Table 150. Auron Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Auron Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 152. Auron Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Auron Therapeutics Main Business
Table 154. Auron Therapeutics Latest Developments
Table 155. Axter Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Axter Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 157. Axter Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Axter Therapeutics Main Business
Table 159. Axter Therapeutics Latest Developments
Table 160. Biotheryx Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Biotheryx PROTAC Therapy Drugs Product Portfolios and Specifications
Table 162. Biotheryx PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Biotheryx Main Business
Table 164. Biotheryx Latest Developments
Table 165. Dialectic Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Dialectic Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 167. Dialectic Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Dialectic Therapeutics Main Business
Table 169. Dialectic Therapeutics Latest Developments
Table 170. Hinova Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Hinova PROTAC Therapy Drugs Product Portfolios and Specifications
Table 172. Hinova PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Hinova Main Business
Table 174. Hinova Latest Developments
Table 175. Hinova Pharmaceuticals Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. Hinova Pharmaceuticals PROTAC Therapy Drugs Product Portfolios and Specifications
Table 177. Hinova Pharmaceuticals PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Hinova Pharmaceuticals Main Business
Table 179. Hinova Pharmaceuticals Latest Developments
Table 180. Haisco Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Haisco PROTAC Therapy Drugs Product Portfolios and Specifications
Table 182. Haisco PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Haisco Main Business
Table 184. Haisco Latest Developments
Table 185. Leadingtac Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 186. Leadingtac PROTAC Therapy Drugs Product Portfolios and Specifications
Table 187. Leadingtac PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 188. Leadingtac Main Business
Table 189. Leadingtac Latest Developments
Table 190. Mitsubishi Tanabe Pharma America Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 191. Mitsubishi Tanabe Pharma America PROTAC Therapy Drugs Product Portfolios and Specifications
Table 192. Mitsubishi Tanabe Pharma America PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 193. Mitsubishi Tanabe Pharma America Main Business
Table 194. Mitsubishi Tanabe Pharma America Latest Developments
Table 195. NiKang Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 196. NiKang Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 197. NiKang Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 198. NiKang Therapeutics Main Business
Table 199. NiKang Therapeutics Latest Developments
Table 200. Ubix Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 201. Ubix Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 202. Ubix Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 203. Ubix Therapeutics Main Business
Table 204. Ubix Therapeutics Latest Developments
Table 205. Foghorn Therapeutics Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 206. Foghorn Therapeutics PROTAC Therapy Drugs Product Portfolios and Specifications
Table 207. Foghorn Therapeutics PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 208. Foghorn Therapeutics Main Business
Table 209. Foghorn Therapeutics Latest Developments
Table 210. Beigene, Ltd. Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 211. Beigene, Ltd. PROTAC Therapy Drugs Product Portfolios and Specifications
Table 212. Beigene, Ltd. PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 213. Beigene, Ltd. Main Business
Table 214. Beigene, Ltd. Latest Developments
Table 215. Jiangsu Hengrui Medicine Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 216. Jiangsu Hengrui Medicine PROTAC Therapy Drugs Product Portfolios and Specifications
Table 217. Jiangsu Hengrui Medicine PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 218. Jiangsu Hengrui Medicine Main Business
Table 219. Jiangsu Hengrui Medicine Latest Developments
Table 220. Qilu Pharmaceutical Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 221. Qilu Pharmaceutical PROTAC Therapy Drugs Product Portfolios and Specifications
Table 222. Qilu Pharmaceutical PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 223. Qilu Pharmaceutical Main Business
Table 224. Qilu Pharmaceutical Latest Developments
Table 225. Simcere Pharma Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 226. Simcere Pharma PROTAC Therapy Drugs Product Portfolios and Specifications
Table 227. Simcere Pharma PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 228. Simcere Pharma Main Business
Table 229. Simcere Pharma Latest Developments
Table 230. Chia Tai Tianqing Pharmaceutical Basic Information, PROTAC Therapy Drugs Manufacturing Base, Sales Area and Its Competitors
Table 231. Chia Tai Tianqing Pharmaceutical PROTAC Therapy Drugs Product Portfolios and Specifications
Table 232. Chia Tai Tianqing Pharmaceutical PROTAC Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 233. Chia Tai Tianqing Pharmaceutical Main Business
Table 234. Chia Tai Tianqing Pharmaceutical Latest Developments


List of Figures
Figure 1. Picture of PROTAC Therapy Drugs
Figure 2. PROTAC Therapy Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PROTAC Therapy Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global PROTAC Therapy Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PROTAC Therapy Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PROTAC Therapy Drugs Sales Market Share by Country/Region (2025)
Figure 10. PROTAC Therapy Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Degradation of Transcription Factors Type
Figure 12. Product Picture of Degradation of Scaffold Proteins Type
Figure 13. Product Picture of Others
Figure 14. Global PROTAC Therapy Drugs Sales Market Share by Type in 2026
Figure 15. Global PROTAC Therapy Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Oral Drugs
Figure 17. Product Picture of Injectable Drugs
Figure 18. Product Picture of Others
Figure 19. Global PROTAC Therapy Drugs Sales Market Share by Administration Route in 2026
Figure 20. Global PROTAC Therapy Drugs Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of CRBN-recruiting PROTACs
Figure 22. Product Picture of VHL-recruiting PROTACs
Figure 23. Product Picture of IAP-recruiting PROTACs
Figure 24. Product Picture of Others
Figure 25. Global PROTAC Therapy Drugs Sales Market Share by E3 Ligase in 2026
Figure 26. Global PROTAC Therapy Drugs Revenue Market Share by E3 Ligase (2021-2026)
Figure 27. PROTAC Therapy Drugs Consumed in Cancer
Figure 28. Global PROTAC Therapy Drugs Market: Cancer (2021-2026) & (K Units)
Figure 29. PROTAC Therapy Drugs Consumed in Immune Diseases
Figure 30. Global PROTAC Therapy Drugs Market: Immune Diseases (2021-2026) & (K Units)
Figure 31. PROTAC Therapy Drugs Consumed in Others
Figure 32. Global PROTAC Therapy Drugs Market: Others (2021-2026) & (K Units)
Figure 33. Global PROTAC Therapy Drugs Sale Market Share by Application (2025)
Figure 34. Global PROTAC Therapy Drugs Revenue Market Share by Application in 2026
Figure 35. PROTAC Therapy Drugs Sales by Company in 2026 (K Units)
Figure 36. Global PROTAC Therapy Drugs Sales Market Share by Company in 2026
Figure 37. PROTAC Therapy Drugs Revenue by Company in 2026 ($ millions)
Figure 38. Global PROTAC Therapy Drugs Revenue Market Share by Company in 2026
Figure 39. Global PROTAC Therapy Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global PROTAC Therapy Drugs Revenue Market Share by Geographic Region in 2026
Figure 41. Americas PROTAC Therapy Drugs Sales 2021-2026 (K Units)
Figure 42. Americas PROTAC Therapy Drugs Revenue 2021-2026 ($ millions)
Figure 43. APAC PROTAC Therapy Drugs Sales 2021-2026 (K Units)
Figure 44. APAC PROTAC Therapy Drugs Revenue 2021-2026 ($ millions)
Figure 45. Europe PROTAC Therapy Drugs Sales 2021-2026 (K Units)
Figure 46. Europe PROTAC Therapy Drugs Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa PROTAC Therapy Drugs Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa PROTAC Therapy Drugs Revenue 2021-2026 ($ millions)
Figure 49. Americas PROTAC Therapy Drugs Sales Market Share by Country in 2026
Figure 50. Americas PROTAC Therapy Drugs Revenue Market Share by Country (2021-2026)
Figure 51. Americas PROTAC Therapy Drugs Sales Market Share by Type (2021-2026)
Figure 52. Americas PROTAC Therapy Drugs Sales Market Share by Application (2021-2026)
Figure 53. United States PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC PROTAC Therapy Drugs Sales Market Share by Region in 2026
Figure 58. APAC PROTAC Therapy Drugs Revenue Market Share by Region (2021-2026)
Figure 59. APAC PROTAC Therapy Drugs Sales Market Share by Type (2021-2026)
Figure 60. APAC PROTAC Therapy Drugs Sales Market Share by Application (2021-2026)
Figure 61. China PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. India PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe PROTAC Therapy Drugs Sales Market Share by Country in 2026
Figure 69. Europe PROTAC Therapy Drugs Revenue Market Share by Country (2021-2026)
Figure 70. Europe PROTAC Therapy Drugs Sales Market Share by Type (2021-2026)
Figure 71. Europe PROTAC Therapy Drugs Sales Market Share by Application (2021-2026)
Figure 72. Germany PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. France PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. UK PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa PROTAC Therapy Drugs Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa PROTAC Therapy Drugs Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa PROTAC Therapy Drugs Sales Market Share by Application (2021-2026)
Figure 80. Egypt PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries PROTAC Therapy Drugs Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of PROTAC Therapy Drugs in 2026
Figure 86. Manufacturing Process Analysis of PROTAC Therapy Drugs
Figure 87. Industry Chain Structure of PROTAC Therapy Drugs
Figure 88. Channels of Distribution
Figure 89. Global PROTAC Therapy Drugs Sales Market Forecast by Region (2027-2032)
Figure 90. Global PROTAC Therapy Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global PROTAC Therapy Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global PROTAC Therapy Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global PROTAC Therapy Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global PROTAC Therapy Drugs Revenue Market Share Forecast by Application (2027-2032)